COVID-19 Updates
News
CDC signs off on COVID boosters in children ages 5-11
Conference Coverage
Pancreatic involvement in COVID-19: What do we know?
“Our data identify the human pancreas as a target of SARS-CoV-2 infection and suggest that pancreatic beta cell involvement could contribute to...
Latest News
Omicron breakthrough cases boost protection, studies say
“We should think about breakthrough infections as essentially equivalent to another dose of vaccine.”
News from the FDA/CDC
FDA authorizes Pfizer’s COVID booster for kids ages 5 to 11
“The omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer-term effects,...
Feature
Children and COVID: New cases up by 50%
Vaccinations continue to decline in younger children, while those aged 12-17 reversed a similar trend.
Conference Coverage
Pfizer COVID vaccine performs well in youth with rheumatic diseases
Nearly all participants in the study showed complete seroconversion, in contrast to similar studies in adults.
From the Journals
Neuropsychiatric risks of COVID-19: New data
“Neuropsychological sequelae need to be considered after all severe respiratory infections, rather than only following severe COVID-19,” said Dr....
Conference Coverage
‘Shielding’ status provides best indicator of COVID-19 mortality in U.K. arthritis population
Shielding status was the highest ranked of all the risk factors identified for early mortality from COVID-19.
From the Journals
Most COVID-19 survivors return to work within 2 years
Survivors report more symptoms than controls, but overall symptom burden decreased over time.
From the Journals
SARS-CoV-2 stays in GI tract long after it clears the lungs
From the Journals
SARS-CoV-2 stays in GI tract long after it clears the lungs
Researchers find COVID RNA remnants in the stool up to 7 months after diagnosis and say that infection of the GI tract may play a role in long...